BBL Campylobacter CSM Agar — Class II medical device recall Z-1805-2013
Terminated recall by Becton Dickinson & Co., reported 2013-07-31, distributed nationwide. Microbiological identification media may exhibit reduced levels of Vancomycin.
| Recall number | Z-1805-2013 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Becton Dickinson & Co., Sparks, MD, United States |
| Recall initiated | 2013-06-06 |
| Classified | 2013-07-24 |
| Reported by FDA | 2013-07-31 |
| Terminated | 2013-09-03 |
| Distributed | Nationwide (US) |
| Countries outside the US | BE, CA, MX, SG, TW |
| Quantity | 293 cartons |
| Reason classes | microbial contamination |
| Lot numbers | 3078430 |
| Model numbers | 299614 |
| Expiration dates | 2013-05-30 |
Product
BBL Campylobacter CSM Agar (Charcoal-Based Selective Medium), Catalog # 299614, packaged in cartons of 20 plates, and labeled in part ***Becton, Dickinson and Company 7 Loveton Circle Sparks, MD 21152 USA 800-638-8663 www.bd.com/ds*** BCYE Selective with PAV is used in qualitative procedures for isolation of Legionella species from clinical specimen and nonclinical (environmental) samples. It is similar to the Edelstein formula, except that the concentration of polymyxin B is reduced by half, and vancomycin is substituted for cefamandole.
Reason for recall
Microbiological identification media may exhibit reduced levels of Vancomycin.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1805-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.